首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >INFLUENCE OF CANCER SEVERITY AND FUNCTIONAL STATUS OF CANCER ON CARDIAC PARASYMPATHETIC INDICATORS
【24h】

INFLUENCE OF CANCER SEVERITY AND FUNCTIONAL STATUS OF CANCER ON CARDIAC PARASYMPATHETIC INDICATORS

机译:癌症严重程度和功能状态对心脏PA散性病理指标的影响

获取原文
获取外文期刊封面目录资料

摘要

Objective: To investigate the influence of cancer severity and functional status of cancer patients on cardiac parasympathetic indicators. Methods: A total of 267 patients with a fresh clinical diagnosis of solid malignant tumor not yet put on cancer therapy and 250 controls matched for age, sex of study subjects were included. Severity of cancer was defined based on the American Joint Committee on Cancer staging. Accordingly, study subjects were subdivided into early stage (Stage I and II combined) and advanced stage (Stage III and IV combined). In cancer patients, the Eastern Cooperative Oncology Group (ECOG) performance score and the Faces Pain Scale score (FPS) was noted. Two indicators of vagal function, expiratory:inspiratory ratio (E:I ratio) and root mean square of successive N-N interval difference (r-MSSD) were included. E:I ratio during deep breathing at six respiratory cycles/minute and r-MSSD at rest was obtained from 1 minute lead II electrocardiogram. Data were analyzed by applying suitable statistical tests. p≤0.05 was considered significant. Results: R-MSSD and E:I ratio was significantly reduced in the early and advanced stage of cancer compared to controls (p≤0.0001). r-MSSD and E:I ratio was significantly reduced in advanced stage compared to the early stage of cancer (p≤0.0001). r-MSSD and E:I ratio was significantly different in subgroups of stages of cancer and controls (p≤0.0001). In cancer patients, r-MSSD was negatively correlated with ECOG and FPS score (p≤0.0278, p≤0.0100). Conclusion: Severity of cancer affects vagal function. However, r-MSSD alone was associated with functional status (ECOG, FPS) of cancer patients.
机译:目的:探讨癌症严重程度和癌症患者的功能状况对心脏副交感神经指标的影响。方法:共纳入267例尚未接受癌症治疗的新鲜诊断为实体恶性肿瘤的临床患者和250名与年龄,性别相匹配的对照。癌症的严重程度是根据美国癌症分期联合委员会确定的。因此,研究对象被分为早期阶段(第一阶段和第二阶段合并)和晚期阶段(第三阶段和第四阶段合并)。在癌症患者中,记录了东部合作肿瘤小组(ECOG)的性能评分和面部疼痛量表评分(FPS)。包括迷走神经功能的两个指标:呼气:吸气比(E:I比)和连续N-N间隔差的均方根(r-MSSD)。从1分钟的Lead II心电图获得深呼吸期间以6个呼吸周期/分钟的E:I比和静止时的r-MSSD。通过应用适当的统计检验来分析数据。 p≤0.05被认为是显着的。结果:与对照组相比,在癌症的早期和晚期,R-MSSD和E:I比率显着降低(p≤0.0001)。与癌症的早期相比,晚期的r-MSSD和E:I比显着降低(p≤0.0001)。在癌症和对照组的亚组中,r-MSSD和E:I比率显着不同(p≤0.0001)。在癌症患者中,r-MSSD与ECOG和FPS评分呈负相关(p≤0.0278,p≤0.0100)。结论:癌症严重程度影响迷走神经功能。但是,仅r-MSSD与癌症患者的功能状态(ECOG,FPS)相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号